Bullish Case: Known: FCPT ~$26.3 and flat since late June; return-surface shows dense likelihood for 0–2y holds with a thick mode around +5% to +10%. Your earlier bearish low-$20s branch didn’t materialize, so base rate shifts toward in-line/range. Inferred: acquisitions (including 6.6% cap-rate vet deal) and monthly dividend support cashflow. Near-term market focus via Aug 21/Sep 18 options: if FFO/AFFO beats (+3%+ y/y) and dividend holds, upside drift (+5–+10%) is supported.

Bearish Case: Known: FCPT return surface still carries meaningful mass in -5% to -12% regions, and longer-hold reds near -12% persist. SPY vol surface shows elevated put-side IV for ~100–250 days, consistent with multiple-compression risk if macro turns. Your prior miss/impairment calls matched “tail-hedge” framing, but timing hasn’t hit—so downside is delayed, not gone. If guidance references impairments, AFFO down, or dilution, -6% to -15% becomes falsifiable.

Potential Outcomes:

Oracle: Aug/Sep filings (FFO/AFFO ±3% y/y; impairment/dilution) and SPY -10%/30d.

1. 50% In-line (+0–5): FFO/AFFO within ±3% y/y, dividend unchanged.
2. 22% Beat (+6–12): FFO/AFFO +3%+ and guidance raised.
3. 20% Miss (-6–15): lease impairments / AFFO guide down.
4. 7% Macro (-10%+): SPY drops >10% in 30d; FCPT de-rates.
5. 1% Re-rate (+12–25): disclosed acquirer or material block buy.

July 23, 2026